Immuron, Inc
Care of Sichenzia Ross Ference LLP, 1185 Avenue of the Americas | 31st Floor | New York, NY 10036
Ph: +1 213 817 5756
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercializing oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle